Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 173

1.

Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia.

Pérez de Isla L, Ray KK, Watts GF, Santos RD, Alonso R, Muñiz-Grijalvo O, Diaz-Diaz JL, Badimon L, Catapano AL, Mata P.

Atherosclerosis. 2019 May 4;286:40-45. doi: 10.1016/j.atherosclerosis.2019.05.003. [Epub ahead of print]

PMID:
31100618
2.

Liquid Biopsy of Extracellular Microvesicles Predicts Future Major Ischemic Events in Genetically Characterized Familial Hypercholesterolemia Patients.

Suades R, Padró T, Crespo J, Sionis A, Alonso R, Mata P, Badimon L.

Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1172-1181. doi: 10.1161/ATVBAHA.119.312420.

PMID:
31070479
3.

VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia.

Miramontes-González JP, Usategui-Martín R, Pérez de Isla L, Alonso R, Muñiz-Grijalvo O, Díaz-Díaz JL, Zambón D, Jiménez FF, Martín-Vallejo J, Rodríguez Gude AE, Jiménez DL, Padro T, González-Sarmiento R, Mata P.

Atherosclerosis. 2019 Jun;285:17-22. doi: 10.1016/j.atherosclerosis.2019.03.019. Epub 2019 Mar 31.

PMID:
30991288
4.

Liquid Biopsy of Extracellular Microvesicles Maps Coronary Calcification and Atherosclerotic Plaque in Asymptomatic Patients With Familial Hypercholesterolemia.

Chiva-Blanch G, Padró T, Alonso R, Crespo J, Perez de Isla L, Mata P, Badimon L.

Arterioscler Thromb Vasc Biol. 2019 May;39(5):945-955. doi: 10.1161/ATVBAHA.118.312414.

PMID:
30866660
5.

Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.

Ellis KL, Pérez de Isla L, Alonso R, Fuentes F, Watts GF, Mata P.

J Am Coll Cardiol. 2019 Mar 12;73(9):1029-1039. doi: 10.1016/j.jacc.2018.12.037.

PMID:
30846097
6.

Adults with familial hypercholesterolaemia have healthier dietary and lifestyle habits compared with their non-affected relatives: the SAFEHEART study.

Arroyo-Olivares R, Alonso R, Quintana-Navarro G, Fuentes-Jiménez F, Mata N, Muñiz-Grijalvo O, Díaz-Díaz JL, Zambón D, Arrieta F, García-Cruces J, Garrido-Sanjuan JA, Banegas JR, Mata P.

Public Health Nutr. 2019 Jun;22(8):1433-1443. doi: 10.1017/S1368980018003853. Epub 2019 Feb 8.

PMID:
30732662
7.

Response to letter entitled "Coronary computed tomography angiogram in familial hypercholesterolemia: A double edge sword" by Dr. Sam Mirzaee and Dr. James D Cameron.

Pérez de Isla L, Alonso R, Mata P.

J Clin Lipidol. 2018 Nov - Dec;12(6):1549-1550. doi: 10.1016/j.jacl.2018.10.001. Epub 2018 Oct 9. No abstract available.

PMID:
30389391
8.

Atherosclerotic cardiovascular disease risk assessment in familial hypercholesterolemia: does one size fit all?

Mata P, Alonso R, Pérez de Isla L.

Curr Opin Lipidol. 2018 Dec;29(6):445-452. doi: 10.1097/MOL.0000000000000553.

PMID:
30382952
9.

ClinVar database of global familial hypercholesterolemia-associated DNA variants.

Iacocca MA, Chora JR, Carrié A, Freiberger T, Leigh SE, Defesche JC, Kurtz CL, DiStefano MT, Santos RD, Humphries SE, Mata P, Jannes CE, Hooper AJ, Wilemon KA, Benlian P, O'Connor R, Garcia J, Wand H, Tichy L, Sijbrands EJ, Hegele RA, Bourbon M, Knowles JW; ClinGen FH Variant Curation Expert Panel.

Hum Mutat. 2018 Nov;39(11):1631-1640. doi: 10.1002/humu.23634.

PMID:
30311388
10.

Familial Hypercholesterolaemia Diagnosis and Management.

Alonso R, Perez de Isla L, Muñiz-Grijalvo O, Diaz-Diaz JL, Mata P.

Eur Cardiol. 2018 Aug;13(1):14-20. doi: 10.15420/ecr.2018:10:2. Review.

11.

Dental hypomineralization treatment: A systematic review.

da Cunha Coelho ASE, Mata PCM, Lino CA, Macho VMP, Areias CMFGP, Norton APMAP, Augusto APCM.

J Esthet Restor Dent. 2019 Jan;31(1):26-39. doi: 10.1111/jerd.12420. Epub 2018 Oct 4. Review.

PMID:
30284749
12.

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

EAS Familial Hypercholesterolaemia Studies Collaboration, Vallejo-Vaz AJ, De Marco M, Stevens CAT, Akram A, Freiberger T, Hovingh GK, Kastelein JJP, Mata P, Raal FJ, Santos RD, Soran H, Watts GF, Abifadel M, Aguilar-Salinas CA, Al-Khnifsawi M, AlKindi FA, Alnouri F, Alonso R, Al-Rasadi K, Al-Sarraf A, Ashavaid TF, Binder CJ, Bogsrud MP, Bourbon M, Bruckert E, Chlebus K, Corral P, Descamps O, Durst R, Ezhov M, Fras Z, Genest J, Groselj U, Harada-Shiba M, Kayikcioglu M, Lalic K, Lam CSP, Latkovskis G, Laufs U, Liberopoulos E, Lin J, Maher V, Majano N, Marais AD, März W, Mirrakhimov E, Miserez AR, Mitchenko O, Nawawi HM, Nordestgaard BG, Paragh G, Petrulioniene Z, Pojskic B, Postadzhiyan A, Reda A, Reiner Ž, Sadoh WE, Sahebkar A, Shehab A, Shek AB, Stoll M, Su TC, Subramaniam T, Susekov AV, Symeonides P, Tilney M, Tomlinson B, Truong TH, Tselepis AD, Tybjærg-Hansen A, Vázquez-Cárdenas A, Viigimaa M, Vohnout B, Widén E, Yamashita S, Banach M, Gaita D, Jiang L, Nilsson L, Santos LE, Schunkert H, Tokgözoğlu L, Car J, Catapano AL, Ray KK; EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Investigators.

Atherosclerosis. 2018 Oct;277:234-255. doi: 10.1016/j.atherosclerosis.2018.08.051.

PMID:
30270054
13.

Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.

Sturm AC, Knowles JW, Gidding SS, Ahmad ZS, Ahmed CD, Ballantyne CM, Baum SJ, Bourbon M, Carrié A, Cuchel M, de Ferranti SD, Defesche JC, Freiberger T, Hershberger RE, Hovingh GK, Karayan L, Kastelein JJP, Kindt I, Lane SR, Leigh SE, Linton MF, Mata P, Neal WA, Nordestgaard BG, Santos RD, Harada-Shiba M, Sijbrands EJ, Stitziel NO, Yamashita S, Wilemon KA, Ledbetter DH, Rader DJ; Convened by the Familial Hypercholesterolemia Foundation.

J Am Coll Cardiol. 2018 Aug 7;72(6):662-680. doi: 10.1016/j.jacc.2018.05.044. Review.

PMID:
30071997
14.

Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study.

Pérez de Isla L, Alonso R, Muñiz-Grijalvo O, Díaz-Díaz JL, Zambón D, Miramontes JP, Fuentes F, Gómez de Diego JJ, González-Estrada A, Mata N, Saltijeral A, Barreiro M, Tomás M, de Andrés R, Argüeso R, Serrano Gotarredona MP, Navarro Herrero S, Perea Palazón RJ, de Caralt TM, Suárez de Centi LA, Zhilina S, Espejo Pérez S, Padró T, Mata P; SAFEHEART investigators.

J Clin Lipidol. 2018 Jul - Aug;12(4):948-957. doi: 10.1016/j.jacl.2018.04.003. Epub 2018 Apr 17.

PMID:
29753733
15.

Multivariate analysis for coronary heart disease in heterozygote familial hypercholesterolemia patients.

Sánchez Muñoz-Torrero JF, Rivas MD, Zamorano J, Joya-Vázquez PP, de Isla LP, Padro T, Mata P, The Safeheart Investigators.

Per Med. 2018 Mar;15(2):87-92. doi: 10.2217/pme-2017-0075. Epub 2018 Jan 31.

PMID:
29714125
16.

Effect of developmental NMDAR antagonism with CGP 39551 on aspartame-induced hypothalamic and adrenal gene expression.

Collison KS, Inglis A, Shibin S, Saleh S, Andres B, Ubungen R, Thiam J, Mata P, Al-Mohanna FA.

PLoS One. 2018 Mar 21;13(3):e0194416. doi: 10.1371/journal.pone.0194416. eCollection 2018.

17.

Cascade screening program for familial hypercholesterolemia.

Rubio-Marín P, Michán-Doña A, Maraver-Delgado J, Arroyo-Olivares R, Barrado Varea R, Pérez de Isla L, Mata P.

Endocrinol Diabetes Nutr. 2018 May;65(5):280-286. doi: 10.1016/j.endinu.2017.12.009. Epub 2018 Mar 6. English, Spanish.

PMID:
29523491
18.

miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemia.

Escate R, Mata P, Cepeda JM, Padró T, Badimon L.

FASEB J. 2018 Feb;32(2):601-612. doi: 10.1096/fj.201700476RR.

PMID:
29457550
20.

Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes.

D'Erasmo L, Minicocci I, Nicolucci A, Pintus P, Roeters Van Lennep JE, Masana L, Mata P, Sánchez-Hernández RM, Prieto-Matos P, Real JT, Ascaso JF, Lafuente EE, Pocovi M, Fuentes FJ, Muntoni S, Bertolini S, Sirtori C, Calabresi L, Pavanello C, Averna M, Cefalu AB, Noto D, Pacifico AA, Pes GM, Harada-Shiba M, Manzato E, Zambon S, Zambon A, Vogt A, Scardapane M, Sjouke B, Fellin R, Arca M.

J Am Coll Cardiol. 2018 Jan 23;71(3):279-288. doi: 10.1016/j.jacc.2017.11.028. Erratum in: J Am Coll Cardiol. 2018 Mar 6;71(9):1058.

Supplemental Content

Support Center